BIT
Click for more information
0.00% 2.2¢ biotron limited

Acceptable TakeOverPrice, page-103

  1. jason_695
    1,024 Posts.
    lightbulb Created with Sketch. 121
    clock Created with Sketch.
    08/10/23
    21:41
    Post #: 70236141

    Thanks for that link! What a revelation! What I most particularly noticed is the extract: INTREPID will publish an initial list of promising antiviral compounds later this year based on publicly available information and derived from a global landscape assessment and scientific evaluation.
    BIT Price at posting: 9.6¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
right-arrow Created with Sketch.
NEWS Form 20-F filed to explore U.S. market opportunities through proposed Nasdaq ADS listing, aligning with strategic global growth goals
right-arrow Created with Sketch.
NEWS Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war
right-arrow Created with Sketch.
NEWS Trending Thread: $13.0 million Institutional Placement
right-arrow Created with Sketch.
NVU Nanoveu To Acquire Leading SoC Semiconductor Company
right-arrow Created with Sketch.
NEWS First-ever treatment for Rett syndrome approved in Canada, opening new possibilities for patients and boosting potential royalty payments—discover more about DAYBUE™'s breakthrough
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
2.2¢ 		Change
0.000(0.00%) 		Mkt cap ! $19.85M
Open High Low Value Volume
2.2¢ 2.3¢ 2.2¢ $8.562K 389.1K

Buyers (Bids)

No. Vol. Price($)
1 228 2.2¢
 

Sellers (Offers)

Price($) Vol. No.
2.3¢ 1991719 1
View Market Depth
Last trade - 14.47pm 18/10/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.